Cargando…
Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice via Inhibition of PKC-α/NFAT Pathway
Familial hypertrophic cardiomyopathy (FHCM), an autosomal dominant disease, is caused by mutations in genes encoding cardiac sarcomeric proteins. E22K, a mutation in the myosin regulatory light chain sarcomere gene, is associated with the development of FHCM. However, the molecular mechanisms by whi...
Autores principales: | Wang, Haiying, Lin, Yuedong, Zhang, Ran, Chen, Yafen, Ji, Wei, Li, Shenwei, Wang, Li, Tan, Rubin, Yuan, Jinxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899095/ https://www.ncbi.nlm.nih.gov/pubmed/35265680 http://dx.doi.org/10.3389/fcvm.2022.808163 |
Ejemplares similares
-
Mitochondrial DNA Depletion Syndrome and Its Associated Cardiac Disease
por: Wang, Haiying, et al.
Publicado: (2022) -
Role of NFAT in the Progression of Diabetic Atherosclerosis
por: Cai, Yaoyao, et al.
Publicado: (2021) -
COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021) -
Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021) -
Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)